Arkeabio
Develops a methane-reducing vaccine for cattle to cut livestock emissions for farmers and food producers
Highlights
- New on EvolcAdded 2026-11-14
About Arkeabio
ArkeaBio is an agricultural bioscience company developing a vaccine that reduces methane emissions from cattle. The vaccine targets methane-producing microbes in the cow's rumen and is given as part of routine care, according to the company's product description.
The company positions the vaccine for cattle farmers, food producers, governments and consumers of beef and dairy. Its stated investors include Breakthrough Energy Ventures, which led a $12 million seed investment in 2022, along with Rabo Ventures, the Grantham Foundation and The51 Food & AgTech Fund.
ArkeaBio is headquartered in Charlestown, Massachusetts, where its site includes a 13,000 square foot lab. Its CEO is Frank Wooten. The careers page lists a general application as the open role.
Product: A methane-reducing vaccine for cattle, given as part of routine care to lower enteric emissions.
Jobs at Arkeabio
More biotech & pharma companies
Ascendis Pharma
Biopharmaceutical therapies for patients with rare endocrine diseases and other medical needsAsimov
Genetic design software, engineered cells and DNA tools for biotechnology and therapeutics developersNew on EvolcAvalyn Pharma
Clinical-stage biopharma developing inhaled drugs for rare lung diseases such as pulmonary fibrosisNew on EvolcAxiom
AI drug-discovery platform that helps pharmaceutical scientists predict and mitigate toxicity before clinical developmentNew on EvolcAxsome Therapeutics
Biopharma developing prescription medicines for psychiatric and neurologic brain disorders such as depression and migraineGrowingBeeline Medicines
Clinical-stage biotechnology company developing oral precision therapies for people with autoimmune and inflammatory diseasesSalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- TermlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- BambooHRMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
